Perceptive Advisors closes $515M fund to fuel more early-stage biotech startups
Perceptive Advisors closes $515M fund to fuel more early-stage biotech startups
Perceptive Advisors has $515 million for its second fund investing in biotech startups. Portfolio Manager Chris Garabedian says Perceptive Xontogeny Ventures Fund II is looking to make Series A investments in early-stage companies with assets that can show a path to clinical testing.
Shares0
When Chris Garabedian set out early last year to raise money for a second Perceptive Advisors fund focused on early-stage biotech startups, it took just a matter of months to draw interest from investors willing to commit more than $1 billion total. The fund could have closed with that much money, maybe more, said Garabedian, the portfolio manager. But it ended up with a little more than half of that, which he described as “the right size.”
(0)
TORONTO and CAMBRIDGE, Mass., May 12, 2021 (GLOBE NEWSWIRE) ProMIS Neurosciences, Inc. (TSX: PMN); (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of antibody therapeutics selectively targeting toxic oligomers implicated in the development of neurodegenerative diseases, today announced the appointment of Rudolph Tanzi, Ph.D, as Chair of the Company s scientific advisory board (SAB). Dr. Tanzi is the Joseph P. and Rose F. Kennedy Professor of Neurology at Harvard University and Vice-Chair of Neurology, Director of the Genetics and Aging Research Unit, and Co-Director of the Henry and Allison McCance Center for Brain Health at Massachusetts General Hospital.
Updated 5/1/2021 5:37 PM
United Way of Lake County has awarded $115,000 in the eighth round of Lake County COVID-19 Response and Recovery Fund grants to eight local nonprofits.
The grants are focused on programs that eliminate barriers to receiving vaccine for homebound adults and/or people of color, or provide access to food for those impacted by the pandemic.
The food program recipients, announced Friday, include A Safe Place, Community Action Partnership of Lake County and West Side Community Center.
The vaccine program recipients include Elderwerks, Erie Family Health Center, Family Service of Lake County and Rosalind Franklin University s Community Care Connection.
Shahriar SheikhBahaei, Ph.D.
Dr. SheikhBahaei’s interest in neuroscience stemmed from the usual combination of an aptitude for science and a medical problem (stuttering) that brought him into bioscience at a young age. Dr. SheikhBahaei received his bachelor’s degree from the University of California at Berkeley, where he worked with Dr. Bob Zucker on the regulation of neurotransmitter release and Dr. John Rubenstein (UC San Francisco) on development of GABAergic neurons in basal ganglia. Dr. SheikhBahaei completed his doctoral studies in Neuroscience (2017) jointly under NIMH/NINDS – University College London (UCL) Graduate Partnership Program where he worked with Drs. Jeffrey Smith (NINDS) and Alexander Gourine (UCL). His graduate studies were on how astrocytic networks control activities of respiratory motor circuits within the brainstem. After short postdoctoral research at NINDS, Dr. SheikhBahaei became an Independent Research Scholar in 2019. In collaboration with the lab